A large UK Biobank cohort analysis identified a bidirectional association between T2DM and IBD. According to findings reported in the Journal of Clinical Gastroenterology, the study evaluated whether IBD increases the risk of developing T2DM and whether T2DM increases the risk of developing IBD. For assessing incident T2DM, the dataset included 4,921 individuals with IBD and 438,948 without IBD. For assessing incident IBD, a separate dataset included 11,649 individuals with T2DM and 438,948 without T2DM. Multivariable Cox proportional hazards regression models were used to calculate adjusted hazard ratios.

During a median follow-up of 12.6 years, individuals with IBD had a higher risk of incident T2DM (HR 1.44; 95% CI 1.31–1.59), including those with UC (HR 1.41; 95% CI 1.26–1.58) and CD (HR 1.62; 95% CI 1.39–1.89). Over a median follow-up of 12.9 years, individuals with T2DM had a higher risk of incident IBD (HR 1.40; 95% CI 1.15–1.69), including UC (HR 1.41; 95% CI 1.13–1.76) and CD (HR 1.48; 95% CI 1.08–2.04). A greater disease severity in either condition was associated with a greater risk of the other. Sensitivity and subgroup analyses by age, sex, and body mass index produced consistent results.

These findings show that T2DM and IBD are bidirectionally associated and linked to increased comorbidity risk. Further research is needed to clarify the shared pathophysiological mechanisms underlying these two chronic conditions.